Presently, the biochemical diagnosis industry is facing fierce competitions in the price, policies, and development models.

The 11th China IVD Industry Development Conference (CIIDC) will be held grandly from March 16-17, 2024, at Chongqing Yuelai International Conference Center in China.

The development of modern immunoassay benefited from the development of labeled immunological technology. The clinical problems, which classical immunoassay could not solve, can be solved by modern immunoassay.

China's in vitro diagnosis began in the 1980s. In the past years, the Chinese IVD industry has been following the trend of national reform and opening up and has made great achievements in the world. At present, China's IVD has developed into a complete industrial chain from reagent instrument system to raw materials and from the domestic market to the global market. Its products have covered all the subdivided fields of the industry and become one of the countries with the most complete product lines of IVD industry in the world.

Recently, the General Office of the State Council communicated Measures of Ministry of Commerce and the Ministry of Science and technology (MOST) for Further Encouraging Foreign Investment in Establishing Research and Development (R&D) Centers in China.

The 10th China IVD Industry Development Conference (CIIDC) is scheduled to be held at Primus Hotel Nanchang International Expo City from May 28 to 29 in 2023.

Recently, executives from multinational medical enterprises intensively visited China or revealed their plans to visit China. It is becoming a common question for most multinational medical businesses to explore how to support China's high-level opening up.